U.S. flag

An official website of the United States government

NM_001142556.2(HMMR):c.1690G>A (p.Ala564Thr) AND Ovarian cancer

Germline classification:
Benign (1 submission)
Last evaluated:
Jan 1, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003154710.2

Allele description [Variation Report for NM_001142556.2(HMMR):c.1690G>A (p.Ala564Thr)]

NM_001142556.2(HMMR):c.1690G>A (p.Ala564Thr)

Genes:
HMMR-AS1:HMMR antisense RNA 1 [Gene - HGNC]
HMMR:hyaluronan mediated motility receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5q34
Genomic location:
Preferred name:
NM_001142556.2(HMMR):c.1690G>A (p.Ala564Thr)
HGVS:
  • NC_000005.10:g.163483272G>A
  • NG_023309.1:g.27762G>A
  • NM_001142556.2:c.1690G>AMANE SELECT
  • NM_001142557.2:c.1429G>A
  • NM_012484.3:c.1687G>A
  • NM_012485.3:c.1642G>A
  • NP_001136028.1:p.Ala564Thr
  • NP_001136029.1:p.Ala477Thr
  • NP_036616.2:p.Ala563Thr
  • NP_036617.2:p.Ala548Thr
  • NC_000005.9:g.162910278G>A
  • NM_001142556.1:c.1690G>A
  • NR_109892.1:n.601C>T
Protein change:
A477T
Molecular consequence:
  • NM_001142556.2:c.1690G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001142557.2:c.1429G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_012484.3:c.1687G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_012485.3:c.1642G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_109892.1:n.601C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Ovarian cancer
Synonyms:
OVARIAN CANCER, SOMATIC
Identifiers:
MONDO: MONDO:0008170; MedGen: C1140680; OMIM: 167000

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV003843493Laboratory of Molecular Epidemiology of Birth Defects, West China Second University Hospital, Sichuan University
criteria provided, single submitter

(ACMG Guidelines, 2015)		Benign
(Jan 1, 2022) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Laboratory of Molecular Epidemiology of Birth Defects, West China Second University Hospital, Sichuan University, SCV003843493.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 17, 2024